HIF1A and melanoma: A recent study demonstrated that Elongator carrying U34 tRNA-modifying activity promotes resistance to targeted therapy in melanoma by enhancing the wobble U34 codon-dependent translation of HIF1α mRNA and maintaining high levels of HIF1α protein45.